ALLMedicine™ Scabies Center

Mar 18th, 2023 - Scabies and Fairyfly: more than meets the eye.|2023|Ranjan E,Arora S,Radhakrishnan S,Rameshkumar A,|

Mar 18th, 2023 - Mass drug administration (MDA) based on two doses of ivermectin, one week apart, substantially reduces prevalence of both scabies and impetigo. The Regimens of Ivermectin for Scabies Elimination (RISE) trial assessed whether one-dose ivermectin-ba...

Mar 15th, 2023 - HONOLULU – A new option for treating scabies, topical spinosad marks a significant development in the scabies treatment landscape, Anthony J. Mancini, MD, said during a presentation at the Hawaii Dermatology Seminar provided by MedscapeLIVE! In Ap.

Mar 7th, 2023 - Oral ivermectin treatment for an infant with crusted scabies.|2023|Bourkas AN,Pope E,|therapeutic use,diagnosis,drug therapy,

Feb 23rd, 2023 - Scabies commonly affects poor populations in low-middle-income countries. The WHO has advocated for country-driven and country-owned control strategies. Knowledge of context specific issues will be important for design and implementation of scabie...

Jun 27th, 2008 - The guideline has been prepared by the Japanese Dermatological Association to ensure proper diagnosis and treatment of scabies, as oral therapy became available on August 2006 under health insurance and its clinical use was expected to increase. F...

Ivermectin is a Food and Drug Administration (FDA)-approved antiparasitic drug used to treat several neglected tropical diseases, including onchocerciasis, helminthiases, and scabies.1 For these indications, ivermectin has been widely used and is ...

Jan 20th, 2023 - Scabies is a skin infestation caused by a mite called Sarcoptes scabiei. Scabies is characterised by a rash and severe itching, which is an allergic reaction to the eggs and feces the females deposit as they tunnel under the skin. Oral ivermectin ...

Jan 19th, 2023 - The aim of the study is to evaluate the prevalence of positive anti BP180 and/or anti BP230 serology in the serum of patients with chronic and diffuse pruritus for at least 1 month under immunotherapy and in the absence of obvious pruritic dermato...

Dec 9th, 2022 - In children, pediculosis is a common ectoparasitic infestation. Infestation of head lice (Pediculus humanus capitis) causes a variety of physical symptoms, including pruritus, excoriation, cervical lymphadenopathy, and conjunctivitis1. It also has...

Dec 1st, 2022 - Children aged 2 to <5years and weighing 10 to <15 kg with clinically diagnosed scabies infection in the participating sites in Laos PDR will be approached for recruitment into the study if eligible (see eligibility criteria) and allocated into one...

Nov 25th, 2022 - Type of study and design The study is a prospective, longitudinal (open) cohort study within households in Sukuta, The Gambia. Households will be recruited, and all available household members asked to participate. Households will be followed for ...

Mar 15th, 2023 - HONOLULU – A new option for treating scabies, topical spinosad marks a significant development in the scabies treatment landscape, Anthony J. Mancini, MD, said during a presentation at the Hawaii Dermatology Seminar provided by MedscapeLIVE! In Ap.

Jan 18th, 2023 - My desk looks nothing like my grandfather’s. It stands about mid-abdomen high and has a small surface, perhaps just enough for the monitor and a mug.

Aug 10th, 2022 - The incidence of lice and scabies decreased significantly among children and adults in North Carolina during the confinement period of the COVID-19 pandemic, between March 2020 and February 2021, according to a report in Pediatric Dermatology. Whe.

Aug 10th, 2022 - The incidence of lice and scabies decreased significantly among children and adults in North Carolina during the confinement period of the COVID-19 pandemic, between March 2020 and February 2021, according to a report in Pediatric Dermatology. Whe...

Jun 24th, 2022 - MADRID — Experts in the field feel it, and evidence proves it: scabies (mange) has become a new "real-time" challenge for dermatologists, especially since the outbreak of the COVID-19 pandemic. Yolanda Gilaberte, MD, PhD, president-elect of the Sp...